Startup India Government of India
Emeritus Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.85 Cr
▼ 6% YoY
Net loss · FY 2025
₹1.76 Cr
Net margin -30.1%
EBITDA · FY 2025
-₹1.94 Cr
EBITDA margin -33.2%
Authorised capital
₹10.5 Lakh
Registered with MCA
Paid-up capital
₹1.42 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
1
Provident fund records
Directors on board
3
As per MCA filings
About Emeritus Pharma Private Limited
Data last updated:
Emeritus Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2017PTC100254. Its GSTIN is 24AAECE8879Q1ZO (Gujarat).
The company has an authorised share capital of ₹10.5 Lakh and a paid-up capital of ₹1.42 Lakh. It is led by directors including Ankur Agarwal and Parasharan Narasimha Chari.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 202 Heritage Skyz B/H Shivalik Prahalad Nagar, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.85 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹1.76 Cr (net margin -30.1%) and EBITDA of -₹1.94 Cr (EBITDA margin -33.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 37% over five years.
The company has about 1 employee on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Medkart. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 2 deals on record (1 secondary share transfer, 1 funding round), with disclosed funding of ₹40.01 Cr; the latest was in May 2021.
Emeritus Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0292914). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emeritus.co.in.
Company details
CIN U51909GJ2017PTC100254
Registration Number 100254
Incorporation Date 26 December 2017
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0292914
Recognitions & Rankings of Emeritus Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0292914
Contact details
Emeritus Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is emeritus.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 202 Heritage Skyz B/H Shivalik Prahalad Nagar, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Emeritus Pharma Private Limited, buy the company report.
Comprehensive company report
Emeritus Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Emeritus Pharma operates one associated brand: Medkart. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform for comparison of prices and purchase of medicines | medkart.in |
Business activity
The main business activity of Emeritus Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Emeritus Pharma Private Limited, buy the company report.
Financials of Emeritus Pharma Private Limited
FY 2025 filings availableEmeritus Pharma Private Limited reported revenue of ₹5.85 Cr (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹5.85 Cr ▼ 6%
Net loss · FY 2025
₹1.76 Cr margin -30.1%
EBITDA · FY 2025
-₹1.94 Cr margin -33.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 18%
5 years · compounded
▲ 37%
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 37%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.76 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -33.2% | ||||
| Net Profit Margin | -30.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emeritus Pharma Private Limited, buy the company report.
Board of directors of Emeritus Pharma Private Limited
Emeritus Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankur Agarwal | Director | 21 Sep 2019 | 7 Years 1 Months | Current |
| Parasharan Narasimha Chari | Director | 29 May 2021 | 5 Years 4 Months | Current |
| Jyoti Narang Also directs: Heidelbergcement India Limited., Brigade Hotel Ventures Limited, Nab Global Innovation Centre India Private Limited and 4 more | Nominee Director | 19 May 2022 | 4 Years 5 Months | Current |
Auditor
Emeritus Pharma Private Limited is audited by M. S. CHHAJED & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. S. CHHAJED & CO. | FY 2024 | 101799W |
Shareholding
The shareholding of Emeritus Pharma Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Emeritus Pharma Private Limited, buy the company report.
Deals & funding
Emeritus Pharma Private Limited has 2 deals on record (1 secondary share transfer, 1 funding round), with disclosed funding of ₹40.01 Cr; the latest was in May 2021.
Total deals
2
Secondary share transfer
1
Funding round
1
Disclosed funding
₹40.01 Cr
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
To see the full deal history of Emeritus Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Emeritus Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Helse Healthcare Private Limited Through Its Authorised Director Dhagasbhai Kiritkumar Shah | Pending |
To see the full case history of Emeritus Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emeritus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Emeritus Pharma has 2 subsidiary companies. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Trakdem Solutions Private Limited | U51397GJ2021PTC122737 | |
| Medkart Pharmacy Private Limited | U74999GJ2019PTC107176 |
To see the full group structure of Emeritus Pharma Private Limited, buy the company report.
Employees & EPFO
Emeritus Pharma Private Limited has a workforce of 1 employees on its EPFO records as of Oct 10, 2025, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Employee growth
-66.67%
GST
Emeritus Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECE8879Q1ZO | Gujarat | Active | 30 Dec 2017 |
To see the full GST registrations and return filing status of Emeritus Pharma Private Limited, buy the company report.
Recent activity
Emeritus Pharma Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Jyoti Narang was appointed as Nominee Director on 19 May 2022.
AGM
Emeritus Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Emeritus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Jyoti Narang was appointed as Nominee Director.
Ceased
Neha Agarwal ceased to be Director.
Appointed
Parasharan Narasimha Chari was appointed as Director.
Ceased
Ankur Agarwal ceased to be Additional Director.
Ceased
Ankit Agarwal ceased to be Director.
Appointed
Ankur Agarwal was appointed as Director.
Incorporation
26 Dec 2017
Emeritus Pharma Private Limited was registered on 26 Dec 2017 with Roc Ahmedabad & aged 8 years 9 months as per MCA records.
Frequently asked questions
Emeritus Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 December 2017 (9+ years old) and is registered under CIN U51909GJ2017PTC100254.
Emeritus Pharma has 3 current directors:
- Ankur Agarwal - Director
- Parasharan Narasimha Chari - Director
- Jyoti Narang - Nominee Director
The latest financial statements of Emeritus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Emeritus Pharma is 24AAECE8879Q1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Emeritus Pharma is U51909GJ2017PTC100254. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emeritus Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Emeritus Pharma was incorporated on 26 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Emeritus Pharma has 2 deals on record (1 secondary share transfer, 1 funding round), with disclosed funding of ₹40.01 Cr; the latest was in May 2021.
Jyoti Narang was appointed as Nominee Director on 19 May 2022. Neha Agarwal ceased to be Director on 15 Sep 2021. Parasharan Narasimha Chari was appointed as Director on 29 May 2021. Emeritus Pharma has 6 board changes on record in total.
Yes, Emeritus Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).